Actively Recruiting
Radical Hypofractionated Radiotherapy for Localized Prostate Cancer
Led by Changhai Hospital · Updated on 2024-08-26
20
Participants Needed
1
Research Sites
365 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this trial is to study the safety outcomes of hypofractionated radiotherapy in treating patients with localized prostate cancer. Hypofractionated radiotherapy delivers higher doses of radiotherapy in a shorter time period, may enabling the killing of more tumor cells with fewer side effects. Accumulating evidence has proven the safety and feasibility of hypofractionated radiotherapy for localized prostate cancer.But for localized prostate cancer,the optimal dose per fraction of hypofractionated radiotherapy is still on its way.
CONDITIONS
Official Title
Radical Hypofractionated Radiotherapy for Localized Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- ECOG performance status of 2 or less
- Pathological diagnosis of prostate cancer
- Clinical stage cTanyN0M0 any Gleason / ISUP group
- Expected survival time greater than 5 years
- No contraindications to radiotherapy and suitable for treatment
- Willingness to undergo radiotherapy and voluntarily accept the study protocol after informed consent
You will not qualify if you...
- Prior treatment for prostate cancer including radiotherapy, chemotherapy, or focal therapy
- Previous pelvic or abdominal radiotherapy
- Prior hormonal therapy such as castration or antiandrogen
- Other malignancies or acute/chronic infections including HIV, hepatitis C, or syphilis
- Considered unsuitable by investigator due to serious systemic diseases or poor compliance
- Contraindications related to radiotherapy
- Participation in other conflicting clinical trials within 4 weeks before study start
- Inability to provide written informed consent or poor treatment compliance
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Changhai hospital
Shanghai, Shanghai Municipality, China, 200433
Actively Recruiting
Research Team
H
Huojun Zhang
CONTACT
X
Xianzhi Zhao
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here